US AI drug discovery firm Chai Discovery has raised $400 million in a Series C financing, valuing the San Francisco-based ...

Biogen (Nasdaq: BIIB) saw its shares fall 8% on Tuesday after a fuller look at mid-stage results for its experimental ...

Japanese pharma major Takeda has agreed a multi-year collaboration with the Indonesian government to build the country’s ...

Chai Discovery has signed a collaboration with Novartis (NOVN: VX) to use artificial intelligence in the discovery of ...

The biotech infrastructure sector has changed significantly since the biotechnology funding peak of 2021. Less venture ...

UK clinical-stage biotech Elevara Medicines today announced the appointment of Mai-Britt Zocca as chief executive (CEO), ...

Medicines regulators in several major markets have issued a mix of approvals, safety communications, supply notices, ...

Japanese drugmaker Eisai today announced the latest findings on etalanetug (development code: E2814) showed that this ...

Elevar Therapeutics, a majority-owned subsidiary of South Korea's HLB (Kosdaq: 028300), has received a complete response ...

US RNA medicines focused biotech Stoke Therapeutics today announced that Thomas McCauley has been appointed chief scientific ...

India's Zydus Lifesciences (BOM: 532321) has entered into a strategic deal to acquire select assets of Sterling Biotech, strengthening its specialty therapies portfolio and expanding manufacturing ...

Roche (ROG: SIX) has discontinued two Huntington’s disease programs, ending the long-running development of tominersen after ...